Seasoned pharmacist and researcher in education and learning sector with work experience of nearly 2 decades, including industrial experience at Ranbaxy Research Laboratories and Smart Analyst Inc. Providing provision of a range of high-quality undergraduate and postgraduate programs which meet the needs of students. Enducing innovation in teaching and learning and curriculum design. Working as an interface between the management and the entire teaching and learning staff, instrumental in embedding consistent and effective policies and
Procedures across all departments. The lead practitioner who challenges the current systems and processes and inspires the entire staff to provide innovative solutions to learning. Currently a student of Law and working on Pharmacy law and Patent law.
Dr. Farid Menaa (Bsc. Eng., Bsc. Bio., Msc. Genetics, Master Gerontology/Geriatry, PhD Radiation Oncology and Gerontology, EMBA Entrepreneurship and MD candidate), is an inter- and multi-disciplinary professional. Professor, Principal Investigator, Director, Consultant Editor, Reviewer, Event Organizer and Entrepreneur, Dr. Menaa earned his degrees with highest distinctions from prestigious French universities and institutions. Dr. Menaa followed a post-doctoral in Oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, Dr. Menaa pursed his career in Dermatology, and Stem Cells as a DFG-Fellow (Wuerzburg, Germany; 2007–2009). Then, Dr. Menaa was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, Dr. Menaa was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010–2012). During his career, Dr. Menaa also followed complementary formations (e.g. Medecine, Pharmacy, Biochemistry, Biophysics, Food Sciences and Technology, Marine Biology, Nano-Biotechnology, Bio-Computation, Bio-Statistics, Business Development and Management, Technological Innovation and Quality). Overall, Dr. Menaa was involved in various R&D projects in multiple areas of medicine/nanomedicine, pharmacy/pharmacology/toxicology, biology, stem cells/tissue engineering, genetics/genomics, fluorine chemistry/biochemistry, biophysics/biophotonics, food science, technology/nanotechnology, and business). His main current focuses are related to preventive, personalized, translational, integrative and nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy. Dr. Menaa has a strong experience with teaching, research and development, supervision, edition, leadership, coaching, consulting, event organizations, scientific & medical collaborations in several countries. Dr. Menaa is, among others, the leading organizer of the Target Meeting´s 1st World Nanomedicine and Nanobiotechnology Online Conference 2013 (http://www.targetmeeting.com), co-organizer of “Nanomaterials Conference” 2013 (Beijing, China) and 2014 (Shenzhen, China), member of the technical committee of the “3rd ScienceOne Conference on Drug Discovery and Development” 2014 (Dubai, UAE). Dr. Menaa is a member of several prestigious organizations (medical and scientific societies), editor, guest editor and reviewer of a large number of esteemed journals worldwide (>50) (e.g. Current Medicinal Chemistry, International Journal of Nanomedicine, Current Organic Chemistry). Among them, he sits on the prestigious editorial boards of Current Drug Therapy (for which is also the lead guest editor of a special issue on nano-pharmaceuticals), Journal of Nanomaterials & Molecular Nanotechnology (JNMN) (for which he is also a guest editor of a special issue on graphene), Journal of Biomaterials and Nanobiotechnology (JBNB), and Journal of Nanomedicine and Biotherapeutics Discovery (JNBD). Dr. Menaa authored and co-authored more than 100 publications (including peer-reviewed ISI research and review articles, books, book chapters, conference proceedings, patents). Dr. Menaa is often invited as a speaker, keynote/featured speaker and (co-)chairman to reputed world congresses and institutions, where he is offering speeches in various areas of medicine, sciences and technology. During his spare time, Dr. Menaa enjoys family, arts, sports and travelling
Experienced Assistant Professor of Chemistry with a demonstrated history of working in the military industry. Skilled in wettability, Colloids, Microfabrication, Nanomaterials, and Chem Draw. Strong education professional with a Doctor of Philosophy (Ph.D.) focused in Physical and Materials Nanochemistry from The University of Hull.
Dr Tarek Mohamed Kamal Mohamed Metawie, Professor of Biochemistry, Faculty of Pharmacy, Cairo University. Egyptian, date of birth 6/3/1955. Ph.D. in Pharmaceutical Sciences, 1984; M.Sc. in Pharmaceutical Sciences, 1979; B.Sc. in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, 1976.
Dr. Blondino has over 20 years of broad based drug development experience in parenteral, oral liquid, and inhalation products. He is currently the Director of Drug Development at Kaleo, Inc. in Richmond, Virginia. He has held industrial positions
Prakash Diwan obtained his PhD from Postgraduate Institute of Medical Education and Research, Chandigarh, India. Contributed in the areas of Novel Drug Delivery systems & drug discovery. Published over 200 papers in pre-reviewed journals. He delivered gue